Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 12, Issue 6 pp 4711—4726
Silencing of lncRNA XIST inhibits non-small cell lung cancer growth and promotes chemosensitivity to cisplatin
Figure 8. Co-regulation of apoptosis and pyroptosis pathways by XIST and SMAD2. (A, B) Western blot analysis of SMAD2, p53, NLRP3, and apoptosis- and pyroptosis-related proteins in NSCLC cells. (C) ChIP assay results indicating reduced interaction of SMAD2 with p53 and NLRP3 following XIST overexpression. (D) Luciferase activity assay showing that SMAD2 knockdown reduces the transcription of p53 and NLRP3. (E) Schematic diagram depicting the potential mechanism mediating XIST-dependent DDP chemoresistance in NSCLC cells.